Get the Stockscreener App
0.4749
7.57%
0.0334
After Hours:
.48
0.0051
+1.07%
Spruce Biosciences Inc stock is traded at $0.4749, with a volume of 1.58M.
It is up +7.57% in the last 24 hours and up +2.19% over the past month.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
See More
Previous Close:
$0.4415
Open:
$0.45
24h Volume:
1.58M
Relative Volume:
3.85
Market Cap:
$18.24M
Revenue:
-
Net Income/Loss:
$-49.11M
P/E Ratio:
-0.2844
EPS:
-1.67
Net Cash Flow:
$-33.81M
1W Performance:
+11.48%
1M Performance:
+2.19%
6M Performance:
-39.57%
1Y Performance:
-78.99%
1-Day Range:
$0.4449
$0.4847
1-Week Range:
$0.426
$0.4847
52-Week Range:
$0.4112
$5.95
Spruce Biosciences Inc Stock (SPRB) Company Profile
Name
Spruce Biosciences Inc
Sector
Industry
Phone
(415) 655-4168
Address
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-21 | Initiated | Oppenheimer | Outperform |
| Dec-10-21 | Initiated | The Benchmark Company | Speculative Buy |
| Nov-16-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jul-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Credit Suisse | Outperform |
| Nov-03-20 | Initiated | RBC Capital Mkts | Outperform |
| Nov-03-20 | Initiated | SVB Leerink | Outperform |
View All
Spruce Biosciences Inc Stock (SPRB) Latest News
Recent Insider Activity Suggests Potential Gains for Spruce Biosciences Inc (SPRB) - Knox Daily
Spruce Biosciences Inc (SPRB) expanding its growth trajectory ahead - SETE News
Spruce Biosciences Inc’s results are impressive - US Post News
Financial Fitness Check: Examining Spruce Biosciences Inc (SPRB)’s Key Ratios - The Dwinnex
Checking in on Spruce Biosciences Inc (SPRB) after recent insiders movement - Knox Daily
Life Time Group Holdings Inc (LTH) gets rating Initiated from Craig Hallum - Knox Daily
Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
Potential Price Increase for Spruce Biosciences Inc (SPRB) After Recent Insider Activity - Knox Daily
SPRBSpruce Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
An Inquiry Has Been Launched Into Whether Spruce Biosciences Inc. Violated Securities Regulations And Stockholders Are Encouraged To Assist - StockTitan
Spruce Biosciences Inc (SPRB) Becoming More Attractive for Investors - Knox Daily
SPRB (Spruce Biosciences) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
SPRB (Spruce Biosciences) Dividends per Share : $0.00 (TTM As of Jun. 2024) - GuruFocus.com
Spruce Biosciences (NASDAQ:SPRB) Issues Quarterly Earnings Results, Beats Expectations By $0.10 EPS - Defense World
What technical indicators reveal about SPRB stock - US Post News
Spruce Biosciences’ (SPRB) Sector Perform Rating Reaffirmed at Royal Bank of Canada - Defense World
Spruce Biosciences Inc [SPRB] Insider Activity: An Update for Investors - Knox Daily
Ratios Reveal: Breaking Down Spruce Biosciences Inc (SPRB)’s Financial Health - The Dwinnex
SPRB stock touches 52-week low at $0.42 amid market challenges - Investing.com Australia
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace
Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - Manchestertimes
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - Business Wire
SPRB stock touches 52-week low at $0.42 amid market challenges - Investing.com
Is Spruce Biosciences Inc (NASDAQ: SPRB) A Good Investment Now? - Stocks Register
Taking a look at what insiders are doing to gauge the Spruce Biosciences Inc (SPRB)’s direction - Knox Daily
Have you been able to find a good deal on Spruce Biosciences Inc’s shares? - US Post News
Market Recap: Spruce Biosciences Inc (SPRB)’s Negative Momentum, Closing at 0.45 - The Dwinnex
Nothing is Better Than Spruce Biosciences Inc (SPRB) stock at the moment - SETE News
Analysts review Spruce Biosciences Inc’s rating - Knox Daily
Ratio Revelations: Spruce Biosciences Inc (SPRB)’s Financial Metrics in the Spotlight - The Dwinnex
SPRB stock touches 52-week low at $0.5 amid market challenges - Investing.com
SPRB stock touches 52-week low at $0.5 amid market challenges - Investing.com Australia
Spruce Biosciences Inc [SPRB] Investment Appeal on the Rise - Knox Daily
Investors With Losses Are Urged To Initiate Dialogue As Spruce B - WICZ
Investors With Losses Are Urged To Initiate Dialogue As Spruce Biosciences Inc Is Being Investigated By The Schall Law Firm - AccessWire
The Schall Law Firm Is Carrying Out An Investigation Into Spruce - WICZ
368,831 Shares in Spruce Biosciences, Inc. (NASDAQ:SPRB) Acquired by Acadian Asset Management LLC - Defense World
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Average Recommendation of “Hold” from Analysts - Defense World
Investors With Losses Encouraged To Initiate Dialogue As Spruce Biosciences Inc Is Being Investigated By The Schall Law Firm - AccessWire
Spruce Biosciences Inc (SPRB) stock: A year of ups and downs - US Post News
The Schall Law Firm Is Investigating Spruce Biosciences Incorpor - WICZ
Investors With Losses Are Urged To Start Conversation, Spruce Bi - WICZ
The Attractiveness of Investing In Spruce Biosciences Inc (SPRB) is Growing - Knox Daily
A closer look at Spruce Biosciences Inc (SPRB)’s stock price trends - US Post News
Layoff Tracker: Bluebird Bio to Cut 25% of Workforce and More News - BioSpace
Daily Market Movement: Spruce Biosciences Inc (SPRB) Sees a 3.65 Increase, Closing at 0.57 - The Dwinnex
Spruce Biosciences, Inc. (NASDAQ:SPRB) Short Interest Update - Defense World
Was Spruce Biosciences Inc (SPRB)’s session last reading good? - US Post News
The Globe and Mail - The Globe and Mail
Spruce Biosciences Inc Stock (SPRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):